[A method for determination of Neisseria meningitidis serogroup A, B, C and W by real-time PCR]

Zhurnal Mikrobiologii, Epidemiologii I Immunobiologii
|March 31, 2015
PubMed
Abstract

Insights

A new real-time PCR method accurately identifies Neisseria meningitidis DNA from cerebrospinal fluid (CSF) samples. This rapid diagnostic tool effectively serogroups common meningococcal strains, aiding in meningitis diagnosis.

Area of Science:

  • Molecular Biology
  • Microbiology
  • Infectious Diseases

Background:

  • Neisseria meningitidis causes bacterial meningitis, a severe infection.
  • Accurate and rapid serogroup identification is crucial for effective treatment and public health response.
  • Existing diagnostic methods may have limitations in speed and specificity.

Purpose of the Study:

  • To develop and validate a real-time PCR assay for detecting Neisseria meningitidis DNA.
  • To enable simultaneous identification of serogroups A, B, C, and W.
  • To assess the method's performance on clinical cerebrospinal fluid (CSF) samples.

Main Methods:

  • Development of multiplex real-time PCR assays targeting specific Neisseria meningitidis serogroup loci.
  • Optimization of PCR conditions for specificity and analytical sensitivity.
  • Testing on reference strains and 187 clinical CSF samples from patients with meningococcal meningitis.

Main Results:

  • The real-time PCR method successfully detected Neisseria meningitidis DNA in clinical samples.
  • Serogroup distribution in CSF samples: A (55%), B (24%), C (16%), W (3%).
  • The assay demonstrated high specificity and sensitivity, with potential for identifying other serogroups.

Conclusions:

  • The developed real-time PCR method can serogroup at least 95% of Neisseria meningitidis strains or DNA from CSF.
  • This method, combined with genotyping techniques, is valuable for comprehensive characterization of pathogenic Neisseria meningitidis.